Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MDGL

Madrigal Pharmaceuticals Inc

Apr 28 • 04:00PM ET

516.69

-3.40 -0.65 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: GILD AKRO VKTX NBIX ENTA SLDB LXRX TSHA NBP RDHL

| Held by: VTI VB IWM VBK XBI VXF IBB IWO SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-12.86	Insider Own	9.14%	Shs Outstand	22.84M	Perf Week	-2.08%
Market Cap	11.85B	Forward P/E	40.44	EPS next Y	12.78	Insider Trans	-5.95%	Shs Float	20.84M	Perf Month	1.18%
Enterprise Value	11.21B	PEG	-	EPS next Q	-4.00	Inst Own	103.33%	Short Float	19.26%	Perf Quarter	3.26%
Income	-288.28M	P/S	12.37	EPS this Y	63.80%	Inst Trans	1.18%	Short Ratio	11.21	Perf Half Y	22.58%
Sales	958.40M	P/B	19.58	EPS next Y	374.62%	ROA	-25.05%	Short Interest	4.01M	Perf YTD	-11.27%
Book/sh	26.39	P/C	11.99	EPS next 5Y	-	ROE	-42.49%	52W High	615.00 -15.99%	Perf Year	55.96%
Cash/sh	43.10	P/FCF	-	EPS past 3/5Y	9.32% 0.37%	ROIC	-30.37%	52W Low	265.00 94.98%	Perf 3Y	65.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	93.98%	Volatility	3.21% 3.50%	Perf 5Y	282.56%
Dividend TTM	-	EV/Sales	11.70	EPS Y/Y TTM	41.81%	Oper. Margin	-31.31%	ATR (14)	19.27	Perf 10Y	3406.55%
Dividend Ex-Date	-	Quick Ratio	3.77	Sales Y/Y TTM	432.05%	Profit Margin	-30.08%	RSI (14)	53.72	Recom	1.28
Dividend Gr. 3/5Y	- -	Current Ratio	4.01	EPS Q/Q	5.30%	SMA20	-1.47%	Beta	-1.05	Target Price	663.47
Payout	-	Debt/Eq	0.58	Sales Q/Q	210.77%	SMA50	7.69%	Rel Volume	0.61	Prev Close	520.09
Employees	915	LT Debt/Eq	0.58	Earnings	May 06 BMO	SMA200	10.81%	Avg Volume	357.98K	Price	516.69
IPO	Feb 06, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	-187.09% 2.75%	Trades		Volume	218,432	Change	-0.65%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)